Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David J. Snyderman currently holds 855,866 shares of MedTech Acquisition Corp (MTAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David J. Snyderman has been a net seller of MTAC stock. They have purchased $0 and sold $673.2M worth of shares.
David J. Snyderman's most recent insider trade was on Oct 31, 2025, when they sold 4,289 shares at $135.10 per share.
David J. Snyderman serves as Executive at MedTech Acquisition Corp (MTAC). They have executed 202 insider transactions totaling $673.2M over their tenure at the company.
David J. Snyderman holds the position of Executive at MedTech Acquisition Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
David J. Snyderman has shown a selling trading pattern, with $0 in total purchases and $673.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David J. Snyderman was on Oct 16, 2025, when they sold $61.5M worth of CRWV shares. This transaction involved 430,691 shares at $142.85 per share.
David J. Snyderman currently owns 855,866 shares of MedTech Acquisition Corp (MTAC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David J. Snyderman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David J. Snyderman has 202 Form 4 filings on record as an insider at MedTech Acquisition Corp.
Set alerts for David J. Snyderman and 40,000+ other insiders.